Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oral amphipathic peptides as therapeutic agents.
Reddy ST, Anantharamaiah GM, Navab M, Hama S, Hough G, Grijalva V, Garber DW, Datta G, Fogelman AM. Reddy ST, et al. Among authors: fogelman am. Expert Opin Investig Drugs. 2006 Jan;15(1):13-21. doi: 10.1517/13543784.15.1.13. Expert Opin Investig Drugs. 2006. PMID: 16370930 Review.
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Hough G, Wagner A, Nakamura K, Garber DW, Datta G, Segrest JP, Hama S, Fogelman AM. Navab M, et al. Among authors: fogelman am. Curr Opin Investig Drugs. 2003 Sep;4(9):1100-4. Curr Opin Investig Drugs. 2003. PMID: 14582455 Review.
Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Wagner AC, Frank JS, Datta G, Garber D, Fogelman AM. Navab M, et al. Among authors: fogelman am. Circulation. 2004 Jun 29;109(25):3215-20. doi: 10.1161/01.CIR.0000134275.90823.87. Epub 2004 Jun 14. Circulation. 2004. PMID: 15197147
Apolipoprotein A-I mimetic peptides.
Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Yu N, Ansell BJ, Datta G, Garber DW, Fogelman AM. Navab M, et al. Among authors: fogelman am. Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1325-31. doi: 10.1161/01.ATV.0000165694.39518.95. Epub 2005 Apr 14. Arterioscler Thromb Vasc Biol. 2005. PMID: 15831812 Review.
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Wagner AC, Hama S, Hough G, Bachini E, Garber DW, Mishra VK, Palgunachari MN, Fogelman AM. Navab M, et al. Among authors: fogelman am. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1932-7. doi: 10.1161/01.ATV.0000174589.70190.e2. Epub 2005 Jun 16. Arterioscler Thromb Vasc Biol. 2005. PMID: 15961700
The double jeopardy of HDL.
Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Hama S, Hough G, Bachini E, Grijalva VR, Wagner AC, Shaposhnik Z, Fogelman AM. Navab M, et al. Among authors: fogelman am. Ann Med. 2005;37(3):173-8. doi: 10.1080/07853890510007322. Ann Med. 2005. PMID: 16019715 Free article. Review.
The role of high-density lipoprotein in inflammation.
Navab M, Anantharamaiah GM, Fogelman AM. Navab M, et al. Among authors: fogelman am. Trends Cardiovasc Med. 2005 May;15(4):158-61. doi: 10.1016/j.tcm.2005.05.008. Trends Cardiovasc Med. 2005. PMID: 16099381 Review.
297 results